SNMMI Podcast Series

SNMMI
  • 0,0 (0)
  • Médecine

Scintillating Conversations: Why Now is the Time to Be in Nuclear Medicine—A Podcast for SNMMI and Nuclear Medicine & Molecular Imaging Professionals

  1. 15 juin

    Industry Podcast: Equal Access, Advanced Imaging: The Role of Mobile PET/CT Today

    Join United Imaging, an SNMMI Value Initiative member, for an insightful discussion with moderator Lance Burrell and speakers Jennifer Robinson, Amanda Dieselkamp, and Will Cofer on the evolving role of mobile PET CT in expanding access to advanced molecular imaging.  This podcast is brought to you by United Imaging, an SNMMI Value Initiative member.  Want more SNMMI content? Follow us on: YouTube | Instagram | LinkedIn | Twitter/X

  2. 8 juin

    So You Want to Be a Medical Physicist...

    Was medical physicist an option at your school's career day? If so, lucky you! But if not, you're not alone. It's a pretty niche field, but it has a significant impact on the future of personalized medicine and treating diseases. If you're thinking that this sounds like an intriguing career path, we're joined by physicists working in several different areas of nuclear medicine: quality control, equipment calibration, and research. Ben Auer, PhD, hosts this episode as we learn more about how our guests discovered their career in medical physics, the qualifications needed, and the various opportunities that come with this highly rewarding field. Tune in now! This episode of the Podcast is sponsored by GE HealthCare. Vizamyl Important Safety Information PRODUCT INDICATIONS AND USE VIZAMYL™(flutemetamol F 18 injection) is indicated for positron-emission tomography (PET) of the brain to estimate amyloid beta neuritic plaque density in adults with cognitive impairment for: Evaluation of Alzheimer's disease(AD) and other causes of cognitive declineSelection of patients who are indicated for amyloid beta-directed therapy as described in the prescribing of information of the therapeutic products.CONTRAINDICATIONS VIZAMYL is contraindicated in patients with a history of hypersensitivity reaction to VIZAMYL or polysorbate 80. ADVERSE REACTIONS The most commonly reported adverse reactions in clinical trials were flushing(2%), increased blood pressure(2%), headache nausea and dizziness(1%). Postmarketing experience included anaphylactic reactions. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure. Prior to VIZAMYL administration, please read the full Prescribing Information for additional Important Safety Information: https://gehealthcare.com/vizamyl-pi  Want more SNMMI content? Follow us on: YouTube | Instagram | LinkedIn | Twitter/X

  3. 6 avr.

    AI: All Hype, A Source of Hope, or Cause for Hesitation?

    This year, 125.6 million people tuned in to watch the Seahawks face the Patriots in the Super Bowl. While the game was the main draw, it's perhaps the one time of year that commercials generate equal excitement. 2026 was no exception, but before the first quarter ended, it was clear which industry dominated the 2026 ad buys: artificial intelligence. AI has become ubiquitous in daily life, and there's almost no industry that hasn't been impacted by its adoption, including nuclear medicine. While some of its applications are clear, questions remain about how AI will be used in clinical settings, patient interactions, image interpretation, and more. On this episode of the SNMMI Podcast, Lance Burrell moderates a discussion with Dmitry Beyer, MPA, CNMT, and Samantha Heasty on AI and its capabilities, potential, and shortcomings. Tune in now! This episode of the SNMMI Podcast is sponsored by GE Healthcare. Important Safety Information – VIZAMYL PRODUCT INDICATIONS AND USE VIZAMYL™ (flutemetamol F 18 injection) is indicated for positron-emission tomography (PET) of the brain to estimate amyloid beta neuritic plaque density in adults with cognitive impairment for: · Evaluation of Alzheimer’s disease (AD) and other causes of cognitive decline · Selection of patients who are indicated for amyloid beta-directed therapy as described in the prescribing of information of the therapeutic products. CONTRAINDICATIONS VIZAMYL is contraindicated in patients with a history of hypersensitivity reaction to VIZAMYL or polysorbate 80. ADVERSE REACTIONS The most commonly reported adverse reactions in clinical trials were flushing (2 %), increased blood pressure (2 %), headache (1 %), nausea and dizziness (1 %). Postmarketing experience included anaphylactic reactions. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure. Prior to VIZAMYL administration, please read the full Prescribing Information for additional Important Safety Information: https://gehealthcare.com/vizamyl-pi Want more SNMMI content? Follow us on: YouTube | Instagram | LinkedIn | Twitter/X

  4. 17 févr.

    The SNMMI Podcast: A Heart-to-Heart on Women’s Cardiac Health

    So much of what we know about heart health is based on male models. Classic heart attack symptoms describe the experiences of men, drugs were developed largely by men for men—even in research, mouse models were male. But in recent years, our understanding of women's cardiac health has expanded, and critically, we have learned that we cannot simply apply male models to female patients. As one of our guests says, "women are not small men." For American Heart Month, join us for a heart-to-heart with members of the SNMMI Cardiovascular Council as they discuss how nuclear cardiology is providing new insight into women's heart health. Listen here or wherever you stream your podcasts.  This episode of the SNMMI Podcast is sponsored by GE Healthcare. Important Safety Information – VIZAMYL PRODUCT INDICATIONS AND USE VIZAMYL™ (flutemetamol F 18 injection) is indicated for positron-emission tomography (PET) of the brain to estimate amyloid beta neuritic plaque density in adults with cognitive impairment for: · Evaluation of Alzheimer’s disease (AD) and other causes of cognitive decline · Selection of patients who are indicated for amyloid beta-directed therapy as described in the prescribing of information of the therapeutic products. CONTRAINDICATIONS VIZAMYL is contraindicated in patients with a history of hypersensitivity reaction to VIZAMYL or polysorbate 80. ADVERSE REACTIONS The most commonly reported adverse reactions in clinical trials were flushing (2 %), increased blood pressure (2 %), headache (1 %), nausea and dizziness (1 %). Postmarketing experience included anaphylactic reactions. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure. Prior to VIZAMYL administration, please read the full Prescribing Information for additional Important Safety Information: https://gehealthcare.com/vizamyl-pi Want more SNMMI content? Follow us on: YouTube | Instagram | LinkedIn | Twitter/X

  5. 15/12/2025

    Neurology and Nuclear Medicine

    Join Phillip Kuo, MD, PhD, and Jacob Dubroff, MD, PhD as they delve into discussions about the latest tracers, brain imaging techniques, and advances in patient care.  To learn more about advancements in neurology in nuclear medicine, register for the upcoming SNMMI Mid-Winter Meeting with a dedicated neurology track. Register Here: https://snmmi.org/MWM/MWM/Attend/Register.aspx  Want more SNMMI content? Follow us on: YouTube | Instagram | LinkedIn | Twitter/X

  6. 04/12/2025

    Part 2 of 2: Nuclear Medicine Physicians for the Future – Closing the Early Exposure Gap

    Join Lance Burrell for a continued conversation on nuclear medicine physicians of the future with Munir Ghesani, MD and Jean-Luc Urbain, MD, PhD. Together, they cover the medical student curriculum, current programs available, and the future of nuclear medicine. Want more SNMMI content? Follow us on: YouTube | Instagram | LinkedIn | Twitter/X

  7. 14/10/2025

    The Science of Seeing: Nuclear Imaging in Breast Cancer Care

    Join Lance Burrell for an insightful conversation with Dr. Gary Ulaner, as they discuss the role of nuclear medicine in breast cancer treatment and lesser-known breast cancer types. Want more SNMMI content? Follow us on: YouTube | Instagram | LinkedIn | Twitter/X

  8. 04/08/2025

    Part 1 of 2: Nuclear Medicine Physicians for the Future – Physician-in-Training Perspective

    Join Dr. Faraz Farhadi and Dr. Navid Hasani as they discuss solutions to recruiting nuclear medicine physicians and expanding the pipeline of trainees. Want more SNMMI content? Follow us on: YouTube | Instagram | LinkedIn | Twitter/X

Tout afficher (25)

À propos

Scintillating Conversations: Why Now is the Time to Be in Nuclear Medicine—A Podcast for SNMMI and Nuclear Medicine & Molecular Imaging Professionals

Informations

  • Création
    SNMMI
  • Années d’activité
    2022 - 2026
  • Épisodes
    25
  • Classification
    Tous publics
  • Copyright
    © 2026 SNMMI Podcast Series
  • Site web de l’émission
    SNMMI Podcast Series